Overcoming chemoresistance in triple negative breast cancer by bromodomain inhibition. (October 2022) - Yedier-Bayram, O.; Cingoz, A.; Aksu, A.C.; Pinarbasi-Degirmenci, N.; Esin, B.; Kayabolen, A.; Cevatemre, B.; Acilan Ayhan, C.; Philpott, M.; Cribbs, A.; Oppermann, U.; Onder, T.T.; et al.